Medicare Enrolled
Dr. Joel Lamon, MD
Hematology & Oncology · San Diego, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lamon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lamon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lamon
Dr. Joel Lamon is a hematology & oncology specialist in San Diego, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lamon performed 137,768 Medicare services across 3,534 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lamon received a total of $6,207 from 57 pharmaceutical and/or device companies across 272 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lamon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in CA
$6,207 industry payments
Medicare Practice Summary
Medicare Utilization ↗137,768
Medicare services
Top 5% in CA for hematology & oncology
3,534
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~7,251 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
68,100 | $2 | $12 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
27,750 | $1 | $9 |
| Denosumab injection (Prolia/Xgeva) | 7,200 | $19 | $51 |
| Pembrolizumab injection (Keytruda) | 6,800 | $44 | $127 |
| Anti-nausea injection (aprepitant) | 6,110 | $1 | $11 |
| Injection, granisetron, extended-release, 0.1 mg | 3,300 | $5 | $20 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
3,260 | $36 | $118 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,800 | $0 | $1 |
| Rituximab-arrx biosimilar injection, 10 mg An injection of rituximab-arrx, a biosimilar medication, administered in a 10 mg dose. |
2,050 | $34 | $185 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,779 | $0 | $8 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
947 | $8 | $20 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
925 | $8 | $11 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
728 | $10 | $27 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
674 | $103 | $418 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
418 | $12 | $40 |
| Anti-nausea injection (Aloxi/palonosetron) | 400 | $1 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
392 | $71 | $286 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
308 | $13 | $35 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
260 | $26 | $87 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
254 | $21 | $64 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
245 | $149 | $558 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
238 | $121 | $400 |
| Iron level test | 218 | $6 | $17 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
218 | $9 | $22 |
| Pegfilgrastim-fpgk biosimilar injection, 0.5 mg An injection of pegfilgrastim-fpgk, a biosimilar medication, administered at a dose of 0.5 mg. |
204 | $274 | $853 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
189 | $6 | $16 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
148 | $19 | $48 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
138 | $1 | $9 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
130 | $58 | $197 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
116 | $16 | $41 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
114 | $9 | $24 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
114 | $1 | $2 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
97 | $26 | $84 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 92 | $285 | $898 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
86 | $99 | $252 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
82 | $1,474 | $4,921 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
72 | $3 | $14 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
69 | $18 | $61 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
66 | $28 | $89 |
| New patient office visit, complex (60-74 min) | 65 | $183 | $594 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
61 | $14 | $47 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
58 | $15 | $38 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
58 | $67 | $222 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
57 | $59 | $194 |
| PSA test (prostate cancer screening) | 41 | $18 | $46 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 38 | $20 | $53 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
34 | $25 | $65 |
| Haptoglobin level test A blood test that measures the amount of haptoglobin, a protein in the serum. It helps evaluate red blood cell breakdown. |
33 | $12 | $32 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
32 | $4 | $12 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $33 | $174 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
27 | $16 | $42 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
25 | $145 | $521 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
25 | $1 | $10 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
21 | $9 | $23 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
16 | $102 | $550 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
16 | $41 | $95 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
15 | $254 | $817 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
14 | $66 | $188 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
11 | $65 | $193 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
23.1% high complexity
72.4% medium
4.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,207
Total received (2018-2024)
Avg $887/year across 7 years
Top 39% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
272
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,888 (94.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$319 (5.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,289
2023
$1,112
2022
$971
2021
$757
2020
$204
2019
$328
2018
$545
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$433
PFIZER INC.
$330
Regeneron Healthcare Solutions, Inc.
$175
GENZYME CORPORATION
$172
BeiGene USA, Inc.
$111
ABBVIE INC.
$102
Aveo Pharmaceuticals, Inc.
$100
AstraZeneca Pharmaceuticals LP
$98
Takeda Pharmaceuticals U.S.A., Inc.
$85
Eisai Inc.
$83
Gilead Sciences, Inc.
$76
ARRAY BIOPHARMA INC
$55
Daiichi Sankyo Inc.
$54
Janssen Biotech, Inc.
$45
SOBI, INC
$45
Bayer Healthcare Pharmaceuticals Inc.
$43
GlaxoSmithKline, LLC.
$40
TAIHO ONCOLOGY, INC.
$28
Celgene Corporation
$27
Incyte Corporation
$24
Agios Pharmaceuticals, Inc.
$22
Karyopharm Therapeutics Inc.
$21
SpringWorks Therapeutics, Inc.
$21
JAZZ PHARMACEUTICALS INC.
$20
Lilly USA, LLC
$18
Exelixis Inc.
$18
E.R. Squibb & Sons, L.L.C.
$17
Pharmacosmos Therapeutics Inc.
$16
Cumberland Pharmaceuticals, Inc.
$14
Top 3 companies account for 40.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$753
PFIZER INC.
$676
Regeneron Healthcare Solutions, Inc.
$354
E.R. Squibb & Sons, L.L.C.
$332
Pharmacyclics LLC, An AbbVie Company
$312
Planmeca USA, Inc.
$260
Genentech USA, Inc.
$225
Pharmacyclics LLC, an AbbVie Company
$189
GENZYME CORPORATION
$172
Seagen Inc.
$161
Gilead Sciences, Inc.
$146
ARRAY BIOPHARMA INC
$146
Amgen Inc.
$143
Eisai Inc.
$137
Teva Pharmaceuticals USA, Inc.
$124
Blueprint Medicines Corporation
$123
BeiGene USA, Inc.
$111
ABBVIE INC.
$102
Takeda Pharmaceuticals U.S.A., Inc.
$100
Aveo Pharmaceuticals, Inc.
$100
AstraZeneca Pharmaceuticals LP
$98
Kite Pharma, Inc.
$96
Karyopharm Therapeutics Inc.
$86
Exelixis Inc.
$85
Janssen Biotech, Inc.
$81
Celgene Corporation
$78
GlaxoSmithKline, LLC.
$72
Bayer Healthcare Pharmaceuticals Inc.
$66
Daiichi Sankyo Inc.
$54
Astellas Pharma US Inc
$53
EMD Serono, Inc.
$50
Octapharma USA, Inc.
$48
SOBI, INC
$45
SERVIER PHARMACEUTICALS LLC
$40
JAZZ PHARMACEUTICALS INC.
$38
TOLMAR Pharmaceuticals, Inc.
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$35
Lilly USA, LLC
$35
AbbVie, Inc.
$32
Epizyme, Inc.,
$30
Cumberland Pharmaceuticals, Inc.
$29
Sun Pharmaceutical Industries Inc.
$28
TAIHO ONCOLOGY, INC.
$28
Alexion Pharmaceuticals, Inc.
$27
MENARINI SILICON BIOSYSTEMS, INC.
$27
Verastem, Inc.
$25
Myovant Sciences Inc.
$24
Incyte Corporation
$24
ADC Therapeutics America, Inc.
$24
MEDIVATION FIELD SOLUTIONS LLC
$23
Agios Pharmaceuticals, Inc.
$22
SpringWorks Therapeutics, Inc.
$21
Jazz Pharmaceuticals Inc.
$19
Clovis Oncology, Inc.
$17
Fresenius Kabi USA, LLC
$17
Sumitomo Pharma America, Inc.
$16
Pharmacosmos Therapeutics Inc.
$16
Top 3 companies account for 28.7% of all-time payments
Associated products mentioned in payments ›
Avastin · BENDEKA · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CARVYKTI · COSELA · CYRAMZA · Cabometyx · Cellsearch · Columvi · Copiktra · DARZALEX · DOPTELET · ELIGARD · ELREXFIO · EPKINLY · Enhertu · FOTIVDA · FRUZAQLA · Fabhalta · GAVRETO · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JADENU · KISQALI · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · Lenvima · Lupron · MEKINIST · MONJUVI · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · ORGOVYX · OXBRYTA · Odomzo · PADCEV · PANZYGA · PIQRAY · PLANMECA EMERALD S · PROMACTA · PYRUKYND · Pomalyst · REBLOZYL · RYBREVANT · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SPRYCEL · SYNAGIS · Stimufend · Stivarga · TASIGNA · TAZVERIK · TIBSOVO · TIVDAK · Tecentriq · Trodelvy · ULTOMIRIS · VERZENIO · VOTRIENT · Venclexta · XALKORI · XGEVA · XPOVIO · XTANDI · Xospata · YERVOY · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
130
Per 100K population
4.0
County median income
$102,285
Nearest hospital
AURORA SAN DIEGO
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lamon is a mixed practice specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lamon experienced with darbepoetin injection (aranesp) for anemia?
Based on Medicare claims data, Dr. Lamon performed 68,100 darbepoetin injection (aranesp) for anemia services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lamon receive payments from pharmaceutical companies?
Yes. Dr. Lamon received a total of $6,207 from 57 companies across 272 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lamon's costs compare to other hematology & oncology specialists in San Diego?
Dr. Lamon's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lamon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in San Diego
Browse hematology & oncology specialists in San Diego ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology